Model:FA, DF EQ
ORLISTAT 120MG C/21 CAPS
Orlistat is used for the treatment of obesity. The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat. Between 16.4% and 24.8% achieved at least a 10% decrease in body mass. After orlistat was stopped, a significant number of subjects regained weight—up to 35% of the weight they had lost.
The incidence of type 2 diabetes in an obese population over four years is decreased with orlistat (6.2%) compared to placebo (9.0%).Long-term use of orlistat also leads to a modest reduction in blood pressure (mean reductions of 2.5 and 1.9 mmHg in systolic and diastolic blood pressure respectively).
Orlistat is notorious for its gastrointestinal side effects which are oily and loose stools. These decrease with time, however, and are the most frequently reported adverse effects of the drug.
Its primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake.
For more information, please contact your medical doctor.